Genmab - DuoBody technology
-
Bispecific antibodies, also known as dual-targeting molecules bind to two different epitopes either on the same or on different targets. This may improve the antibodies' specificity and efficacy in inactivating the disease target cells. Watch this short video to learn how Genmab's DuoBody
technology platform draws inspiration from nature to enable the discovery, generation and large-scale production of effective bispecific antibodies.Visit https://https://www.genmab.com/research-innovation/ to learn more about .
-
"I pipelinen findes blandt andet produkter som Epcoritamab og DuoBodyPD-L1x4-1BB samt HexaBody-CD38. I et scenarie, hvor alle produkter godkendes, estimerer Jyske Bank, at kursen kan kravle op i 4200 kr., hvilket svarer til en fordobling af den nuværende kurs".
-
Pappano...Du finder først nyhederne her på Proinvestor. Vi havde en god debat om denne i Genmabchatten i går.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind